Tamoxifen Resistance in Women With Stage I, Stage II, Stage IIIA, or Stage IIIB Breast Cancer
Status: TERMINATED
Study type: OBSERVATIONAL
Conditions: Breast Cancer
Interventions: DRUG: tamoxifen citrate|GENETIC: gene expression analysis|GENETIC: protein expression analysis|OTHER: immunoenzyme technique|OTHER: laboratory biomarker analysis
Sponsor: Wake Forest University Health Sciences
Collaborators: National Cancer Institute (NCI)